Market Research Report
Allogeneic Stem Cells
|Allogeneic Stem Cells|
Published: April 1, 2021
Global Industry Analysts, Inc.
Content info: 171 Pages
Delivery time: 1-2 business days
Global Allogeneic Stem Cells Market to Reach $1.4 Billion by 2027
Amid the COVID-19 crisis, the global market for Allogeneic Stem Cells estimated at US$666.3 Million in the year 2020, is projected to reach a revised size of US$1.4 Billion by 2027, growing at aCAGR of 10.6% over the period 2020-2027. Regenerative Therapy, one of the segments analyzed in the report, is projected to record 11.5% CAGR and reach US$869.6 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Drug Discovery & Development segment is readjusted to a revised 9.2% CAGR for the next 7-year period.
The U.S. Market is Estimated at $179.9 Million, While China is Forecast to Grow at 14.2% CAGR
The Allogeneic Stem Cells market in the U.S. is estimated at US$179.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$292.7 Million by the year 2027 trailing a CAGR of 14.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.3% and 9.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8.3% CAGR.
Select Competitors (Total 33 Featured) -